Guideline on the investigation, management and prevention of venous thrombosis in children

British Journal of Haematology

Volumn 154, Issue 2, 2011, Pages 196-207

  Chalmers, Elizabeth ^a   Ganesen, Vijeya ^b   Liesner, Ri ^b   Maroo, Sanjay ^a   Nokes, Timothy ^c   Saunders, D ^b   Williams, Michael ^d  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c DERRIFORD HOSPITAL   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Child; Paediatric haematology; Paediatric thrombosis; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; DALTEPARIN; DANAPAROID; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; LEPIRUDIN; LEVOSIMENDAN; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN; TINZAPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VITAMIN K GROUP; WARFARIN;

ACUTE DISEASE; ANTITHROMBIN DEFICIENCY; ARTICLE; CHILDHOOD MORTALITY; COMPRESSION GARMENT; COMPRESSION THERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DRUG CONTRAINDICATION; ECHOGRAPHY; FILTER; FULMINATING PURPURA; GENETIC DISORDER; HEALTH CARE PERSONNEL; HEMOSTASIS; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LABORATORY TEST; LEG THROMBOSIS; LOADING DRUG DOSE; LUNG EMBOLISM; MEDICAL SPECIALIST; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PEDIATRICIAN; PHLEBOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT; THROMBOLYTIC THERAPY; THROMBOPHILIA; VENA CAVA FILTERS; VENOUS THROMBOEMBOLISM;

EID: 79959855311     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08543.x     Document Type: Article

References (87)

1. Amarigiri, SV & Lees, TA. (2010) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database of Systematic Reviews, Issue 7. Art. No.: CD001484.
2. Andrew, M, Booker, L & Leaker, M. (1992) Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thrombosis and Haemostasis, 68, 325-330.
3. Andrew, M, David, M, Adams, M, Ali, K, Anderson, R, Barnard, D, Bernstein, M, Brisson, L, Cairney, B, DeSai, D, Grant, R, Israels, S, Jardine, L, Luke, B, Massicotte, P & Silva, M. (1994a) Venous thromboembolic complications (VTE) in Children: First analyses of the Canadian Registry of VTE. Blood, 83, 1251-1257.
4. Andrew, M, Marzinotto, V, Massicotte, P., Blanchette, V., Ginsberg, J., Brill-Edwards, P., Burrows, P., Benson, L., Williams, W. & David, M. (1994b) Heparin therapy in pediatric patients: a prospective cohort study. Pediatric Research;, 35, 78-83.
5. Atkins, D, Best, D, Briss, P.A., Eccles, M., Falck-Ytter, Y., Flottorp, S., Guyatt, G.H., Harbour, R.T., Haugh, M.C., Henry, D., Hill, S., Jaeschke, R., Leng, G., Liberati, A., Magrini, N., Mason, J., Middleton, P., Mrukowicz, J., O'Connell, D., Oxman, A.D., Phillips, B., Schünemann, H.J., Edejer, T.T., Varonen, H., Vist, G.E., Williams, Jr, J.W. & Zaza, S; GRADE Working Group (2004) Grading quality of evidence and strength of recommendations. BMJ, 328, 1490-1494.
6. Baglin, T. (2006) Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet. Journal of Thrombosis and Haemostasis, 4, 2530-2532.
7. Baglin, TP, Keeling, DM & Watson, HG. (2005) Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. British Journal of Haematology, 132, 277-285.
8. Baglin, TP, Brush, J & Streiff, M; on behalf of the BCSH (2006) Guidelines on use of vena cava filters. British Journal of Haematology, 134, 590-595.
9. Baglin, T, Gray, E, Greaves, M, Hunt, BJ, Keeling, D, Machin, S, Mackie, I, Makris, M, Nokes, T, Perry, D, Tait, RC, Walker, I & Watson, H. (2010) Clinical guidelines for testing for heritable thrombophilia. British Journal of Haematology, 149, 209-220.
10. Baumgartner, R. W., Studer, A., Arnold, M. & Georgiadis, D. (2003) Recanalisation of cerebral venous thrombosis. Journal of Neurology, Neurosurgery, and Psychiatry;, 74, 459-461.
11. Bidlingmaier, C, Magnani, H. N, Girisch, M & Kurnik, K. (2006) Safety and efficacy of danaparoid (Orgaran) use in children. Acta Haematologica, 115, 237-247.
12. Biss, TT, Brandao, LR, Kahr, WH, Chan, AK & Williams, S. (2008) Clinical features and outcome of pulmonary embolism in children. British Journal of Haematology, 142, 808-818.
13. Bolton-Maggs, P & Brook, L. (2002) The use of vitamin K for the reversal of over warfarinisation in children. British Journal of Haematology, 118, 924.
14. Bonduel, M, Hepner, M, Sciuccati, G, Torres, AF, Pieroni, G & Frontroth, JP. (2000) Prothrombotic abnormalities in children with venous thromboembolism. Journal of Pediatric Hematology/Oncology, 22, 66-72.
15. British Thoracic Society Standards of care Committee Pulmonary Embolism Guideline Development Group (2003) British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 58:470-484.
16. Buller, HR, Agnelli, G, Hull, RD, Hyers, TM, Prins, MH & Raskob, GE. (2004) Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(3 Suppl.), 401S-428S.
17. Cahn, MD, Rohrer, MJ, Martella, MB & Cutler, BS. (2001) Long term follow up of Greenfield inferior vena cava filter placement in children. Journal of Vascular Surgery, 34, 820-825.
18. Chalmers, EA. (2006) Epidemiology of venous thrombosis in neonates and children. Thrombosis Research;, 118, 3-12.
19. Chalmers, EA, Mcintosh, N, Gibson, B & Watt, A. (2003) Catheter related thrombosis in children diagnosed by magnetic resonance venography. Abstracts from X1X international ISTH Congress. Journal of Thrombosis and Haemostasis, 1(Suppl. 1), P0045.
20. Chan, A K, Deveber, G, Monagle, P, Brooker, LA & Massicotte, PM. (2003) Venous thrombosis in children. Journal of Thrombosis and Haemostasis, 1, 1443-1455.
21. Ciccone, A., Canhao, P., Falcao, F., Ferro, J. M. & Sterzi, R. (2004) Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD003693.
22. De Stefano, V, Simioni, P., Rossi, E., Tormene, D., Za, T., Pagnan, A. & Leone, G. (2006) The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica, 91, 695-698.
23. De Veber, G., Andrew, M., Adams, C., Bjornson, B., Booth, F., Buckley, DJ., Camfield, CS., David, M., Humphreys, P., Langevin, P., MacDonald, EA., Gillett, J., Meaney, B., Shevell, M., Sinclair, DB. & Yager, J.; Canadian Pediatric Ischemic Stroke Study Group. (2001) Cerebral sinovenous thrombosis in children. The New England Journal of Medicine, 345, 417-423.
24. Dix, D., Andrew, M., Marzinotto, V., Charpentier, K., Bridge, S., Monagle, P., deVeber, G., Leaker, M., Chan, AK. & Massicotte, MP. (2000) The use of low molecular weight heparin in pediatric patients: a prospective cohort study. Journal of Pediatrics, 136, 439-445.
25. Dormont, D, Anxionnat, R, Evrard, S, Louaille, C & Marsault, C. (1994) MRI in cerebral venous thrombosis. Journal of Neuroradiology, 21, 81-99.
26. Ehrenforth, S, Junker, R, Koch, H-G, Kreuz, W, Münchow, N, Scharrer, I & Nowak-Göttl, U. (1999) Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. European Journal of Pediatrics, 158(Suppl. 3), S97-S104.
27. Eichinger, S, Minar, E, Bialonczyk, C, Hirschl, M, Quehenberger, P, Schneider, B, Weltermann, A, Wagner, O & Kryle, PA. (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA, 290, 1071-1074.
28. Fraser, DG, Moody, AR, Davidson, IR, Martel, AL & Morgan, PS. (2003) Deep venous thrombosis: diagnosis by using venous enhanced subtracted peak arterial MR venography versus conventional venography. Radiology, 226, 812-820.
29. Geerts, WH, Bergqvist, D., Pineo, GF., Heit, JA., Samama, CM., Lassen, MR. & Colwell, CW. (2008) Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 338S-400S.
30. Gibson, BES, Chalmers, EA, Bolton-Maggs, P, Henderson, DJ & Lynn, R. (2004) Thromboembolism in childhood: a prospective two-year BPSU study in the United Kingdom. British Journal of Haematology, 125(Suppl. 1), 1.
31. Goldenberg, NA., Knapp-Clevenger, R. & Manco-Johnson, MJ; Mountain States Regional Thrombophilia Group (2004) Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. New England Journal of Medicine, 351, 1081-1088.
32. Goldenberg, NA, Durham, JD, Knapp-Clevenger, R & Manco-Johnson, MJ. (2007) A thrombolytic regimen for high-risk deep venous thrombosos may substantially reduce the risk of postthrombotic syndrome in children. Blood, 110, 45-53.
33. Gupta, AA, Leaker, M, Andrew, M, Massicotte, P., Liu, L., Benson, LN. & McCrindle, BW. (2001) Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. Journal of Pediatrics, 139, 682-688.
34. Guyatt, GH, Oxman, AD, Vist, GE, Kunz, R, Falck-Ytter, Y, Alonso-Coello, P & Schünemann, HJ. (2008a) GRADE: An emerging concensus on rating quality of evidence and strength of recommendations. BMJ, 336, 924-926.
35. Guyatt, GH, Oxman, AD, Kunz, R, Falck-Ytter, Y, Vist, GE, Liberati, A & Schünemann, HJ. (2008b) GRADE: going from evidence to recommendations. BMJ, 336, 1049-1051.
36. Hagstrom, JN, Walter, J, Bluebond-Langner, R, Amatniek, JC, Manno, CS & High, KA. (1998) Prevalence of the factor V Leiden mutation in childen and neonates with thromboembolic disease. The Journal of Pediatrics, 133, 777-781.
37. Haider, E. A, Rosen, J. C, Torres, C & Valenti, D. A. (2005) Serial repositioning of a Günther tulip retrievable inferior vena cava filter in a pediatric patient. Pediatric Radiology, 35, 1135-1138.
38. Heller, C., Heinecke, A., Junker, R., Knöfler, R., Kosch, A., Kurnik, K., Schobess, R., von Eckardstein, A., Sträter, R., Zieger, B. & Nowak-Göttl, U; Childhood Stroke Study Group (2003) Cerebral venous thrombosis in children: a multifactorial origin. Circulation, 108, 1362-1367.
39. Idbiah, A, Boukoba, M, Crassard, I, Porcher, R, Bousser, MG & Chabriat, H. (2006) MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted imaging. Stroke, 37, 991-995.
40. Journeycake, JM & Manco- Johnson, MJ. (2004) Thrombosis during infancy and childhood: what we know and what we don't know. Hematology/oncology Clinics of North America, 18, 1315-1338.
41. Kearn, C, Julian, MM, Newman, TE & Ginsberg, JS. (1998) Non invasive diagnosis of deep venous thrombosis. Annals of Internal Medicine, 128, 663-677.
42. Kenet, G., Waldman, D., Lubetsky, A., Kornbrut, N., Khalil, A., Koren, A., Wolach, B., Fattal, A., Kapelushnik, J., Tamary, H., Yacobovitch, J., Raveh, E., Revel-Vilk, S., Toren, A. & Brenner, B. (2004) Paediatric cerebral sinus vein thrombosis. A multi-center case-controlled study. Thrombosis and Haemostasis, 92, 713-718.
43. Kenet, G, Kirkham, F, Niederstadt, T, Heinecke, A, Saunders, D, Stoll, M, Brenner, B, Bidlingmaier, C, Heller, C, Knöfler, R, Schobess, R, Zieger, B, Sébire, G & Nowak-Göttl, U; European Thromboses Study Group (2007) Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurology, 6, 595-603.
44. Lafitte, F, Boukobza, M, Guichard, JP, Hoeffel, C., Reizine, D., Ille, O., Woimant, F. & Merland, JJ. (1997) MRI and MRA for diagnosis and follow up of cerebral venous thrombosis. Clinical Radiology, 52, 672-697.
45. Legani, C, Cosmi, B, Cini, M, Frascaro, M, Guazzaloca, G & Palareti, G. (2004) High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. British Journal of Haematology, 124, 504-510.
46. Male, C, Chait, P, Ginsberg, J, Hanna Andrew, K., Halton, M., Anderson, J., McCusker, R., Wu, P., Abshire, J., Cherrick, T., Mahoney, I. & Mitchell, D. L. (2002) Comparision of venography and ultrasound for the diagnosis of asymptomatic deep venous thrombosis in the upper body in children results of the PARKAA study. Prophylactic Anti thrombin replacement in Kids with ALL treated with asparaginase. Thrombosis and Haemostasis., 87, 593-598.
47. Male, C, Chait, P, Andrew, M, Hanna, K, Julian, J. & Mitchell, L.; PARKAA Investigators (2003) Central Venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood, 101, 4273-4278.
48. Male, C, Julian, JA, Massicotte, P, Gent, M & Mitchell, L; PROTEKT study group (2005) Significant association with location of central venous line placement and risk of venous thrombosis in children. Thrombosis and Haemostasis, 94, 516-521.
49. Manco-Johnson, M.J. (2006) How I treat venous thrombosis in children. Blood, 107, 21-29.
50. Massicotte, P, Adams, M, Marzinotto, V, Brooker, L & Andrew, M. (1996) Low molecular weight heparin in pediatric patients with thrombotic disease: a dose finding study. The Journal of Pediatrics, 128, 313-318.
51. Massicotte, P., Leaker, M., Marzinotto, V., Adams, M., Freedom, R., Williams, W., Vegh, P., Berry, L., Shah, B. & Andrew, M. (1998) Enhanced thrombin regulation during warfarin therapy in children compared to adults. Thrombosis and Haemostasis, 80, 570-574.
52. Massicotte, P, Julian, JA, Gent, M, Shields, K., Marzinotto, V., Szechtman, B. & Andrew, M.; REVIVE Study Group (2003a) An open-label randomized controlled trial of low molecular-weight heparin and coumarin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thrombosis Research, 109, 85-92.
53. Massicotte, P, Julian, JA, Gent, M, Shields, K, Marzinotto, V, Szechtman, B, Chan, AK & Andrew, M.; PROTEKT study group (2003b) An open label randomised control trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children; The PROTEKT trial. Thrombosis Research, 109, 101-108.
54. Miga, DE, McKellar, LF, Denslow, S, Wiles, HB, Case, CL & Gillette, PC. (1997) Incidence of femoral vein occlusion after catheter ablation in children: evaluation with magnetic resonance angiography. Pediatric Cardiology, 18, 204-207.
55. Monagle, P, Adams, M, Mahoney, M, Ali, K, Barnard, D, Bernstein, M, Brisson, L, David, M, Desai, S, Scully, MF, Halton, J, Israels, S, Jardine, L, Leaker, M, McCusker, P, Silva, M, Wu, J, Anderson, R, Andrew, M & Massiotte, MP. (2000) Outcome of pediatric thrombophilic disease: a report from the Canadian Thrombophilia Registry. Pediatric Research, 4, 763-766.
56. Monagle, P, Chan, A, Massicotte, P, Chalmers, E. & Michelson, A.D. (2008) Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 133, 887-968.
57. Newall, FH, Barnes, CB, Savoia, HF, Campbell, J. & Monagle, P. (2003) Warfarin therapy in children requiring long term total parenteral nutrition (TPN). Paediatrics, 112, e386.
58. Newall, F, Wallce, T, Crock, C, Campbell, J, Savoia, H, Barnes, C & Monagle, P. (2006) Venous thromboembolic disease: a single centre case-series study. Journal of Paediatrics and Child Health, 42, 803-807.
59. Nilsson, T, Mare, K & Carlsson, A. (2001) Value of structured clinical and scintigraphic protocols in acute pulmonary embolism. Journal of the Institute of Medicine, 250, 213-218.
60. Nohe, N., Flemmer, A., Rümler, R., Praun, M. & Auberger, K. (1999) The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. European Journal of Pediatrics, 158, S134-S139.
61. Nowak-Gottl, U, Junker, R, Kreuz, W, von Eckardstein, A, Kosch, A, Nohe, N, Schobess, R & Ehrenforth, S.; Childhood Thrombophilia Study Group (2001) Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood, 97, 858-862.
62. Nuss, R, Hays, T, Chudgar, U & Manco-Johnson, M. (1997) Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli. Journal of Pediatric Hematology/oncology, 19, 202-207.
63. van Ommen, CH, Heijboer, H, Büller, HR, Hirasing, RA, Heijmans, HAS & Peters, M. (2001) Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. The Journal of Pediatrics, 139, 676-681.
64. van Ommen, CH, Heijboer, H, van den Dool, EJ, Hutten, BA & Peters, M. (2003) Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. Journal of Thrombosis and Haemostasis, 1, 2516-2522.
65. Osvarth, RR, Casey, SO, Lustrin, ES, Alberico, RA, Hassankhani, A & Patel, M. (1997) Cerebral venogrpahy: comparison of CT and MR projection venography. American Journal of Roentgenology, 169, 1699-1707.
66. Palareti, G, Legnani, C, Cosmi, B, Guazzaloca, G, Pancani, C & Coccheri, S. (2002) Risk of venous thromboembolic recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thrombosis and Haemostasis, 87, 7-12.
67. Palareti, G, Cosmi, B, Legnani Tosetto, C A, Brusi, C, Iorio, A, Pengo, V, Ghirarduzzi, A, Pattacini, C, Testa, S, Lensing, AWA & Tripodi, A. (2006) D-dimer testing to determine the duration of anticoagulation therapy. The New England Journal of Medicine, 355, 1780-1789.
68. Pierce, CM, Wade, A & Mok, Q. (2000) Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Medicine, 26, 967-972.
69. Punzalan, R.C., Hillery, C.A, Montgomery, R.R., Scott, C.A. & Gill, J.C. (2000) Low-molecular weight heparin in thrombotic disease in children and adolescents. Journal of Pediatric Hematology/Oncology, 22, 137-142.
70. Raffini, L & Thornburg, C. (2009) Testing children for inherited thrombophilia: more questions than answers. British Journal of Haematology, 147, 277-288.
71. Reed, RA, Teitelbaum, GP, Stanley, P, Mazer, MJ, Tonkin, IL & Rollins, NK. (1996) The use of inferior vena cava filters in paediatric patients for pulmonary embolus prophylaxis. Cardiovascular and Interventional Radiology, 19, 401-405.
72. Revel-Vilk, S, Chan, A, Bauman, M & Massicotte, P. (2003) Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. Journal of Thrombosis and Haemostasis, 1, 915-921.
73. Ruud, E, Holstrom, H, De Lange, C, Hogstad, EM & Wesenberg, EF. (2006) Low dose Warfarin for the prevention of central line associated thromboses in children with malignancies - a randomised controlled study. Acta Paediatrica, 95, 1053-1059.
74. Santilli, J. (2002) Fibrin Sheaths and Central Venous Catheter Occlusions: Diagnosis and management. Techniques in Vascular and Interventional radiology., 5, 89-94.
75. Schobess, R, Junker, R, Auberger, K, Münchow, N, Burdach, S & Nowak-Göttl, U. (1999) Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin 20210A mutation. European Journal of Pediatrics, 158(Suppl. 3), S105-S108.
76. Sebire, G., Tabarki, B., Saunders, DE., Leroy, I., Liesner, R., Saint-Martin, C., Husson, B., Williams, AN., Wade, A. & Kirkham, FJ. (2005) Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain, 128, 477-489.
77. Shankar, KR, Abernethy, LJ, Das, KSV, Roche, CJ, Pizer, BL, Lloyd, DA & Losty, PD. (2002) Magnetic resonance venography in assessing venous patency after multiple venous catheters. Journal of Pediatric Surgery, 37, 175-179.
78. Sosothikul, D., Seksarn, P. & Lusher, JM. (2007) Pediatric reference values for molecular markers in hemostasis. Journal of pediatric hematology/oncology, 29, 19-22.
79. Spencer, F.A. & Goldberg, R.J. (2005) Asymptomatic thrombophilia - a family affair. Journal of Thrombosis and Haemostasis, 3, 457-458.
80. Stam, J., de Bruijn, S. & deVeber, G. (2003) Anticoagulation for cerebral sinus thrombosis. Stroke, 34, 1054-1055.
81. Stein, PD, Hull, Rd, Patel, KC, Olson, RE, Ghali, WA, Brant, R, Biel, RK, Bharadia, V & Kalra, NK. (2004) D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism a systematic review. Annals of Internal Medicine, 140, 589-602.
82. Streif, W., Andrew, M., Marzinotto, V., Massicotte, P., Chan, A.K., Julian, J.A. & Mitchell, L. (1999) Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood, 94, 3007-3014.
83. Strupp, M., Covi, M., Seelos, K., Dichgans, M. & Brandt, T. (2002) Cerebral venous thrombosis: correlation between recanalization and clinical outcome-a long-term follow-up of 40 patients. Journal of Neurology, 249, 1123-1124.
84. Verhovsek, M., Douketis, J.D., Yi, Q., Shrivastava, S., Tait, R.C., Baglin, T., Poli, D. & Lim, W. (2008) Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Annals of Internal Medicine, 149, 481-490.
85. Wang, M, Hays, T, Balasa, V, Bagatell, R, Gruppo, R., Grabowski, E.F, Valentino, L.A., Tsao-Wu, G & Manco-Johnson, M.J.; Pediatric Coagulation Consortium (2003) Low-dose tissue plasminogen activator thrombolysis in children. Journal of pediatric hematology/oncology, 25, 379-386.
86. Williams, S, Chait, P, Temple, M, Connolly, B, Chan, AK, Bauman, M, Ash, M & Massicotte, P. (2003) Vena cava filters in children: a review of a single centre clinical experience over 7 years. Journal of Thrombosis and Haemostasis, 1(Suppl. 1), OC439.
87. Young, G., Becker, S., During, C., Friedrichs, F., Goldenberg, N., Kenet, G., Manco-Johnson, M., Scheffold., C. & Nowak-Gottl, U. (2009) Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter cohort study. Journal of Thrombosis and Haemostasis, 7, 72-79.